Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
15.60
+0.02 (0.13%)
Sep 21, 2026, 4:00 PM EDT - Market closed
Carlsmed Revenue
Carlsmed had revenue of $18.94M in the quarter ending June 30, 2026, with 56.75% growth. This brings the company's revenue in the last twelve months to $63.30M, up 65.39% year-over-year. In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth.
Revenue (ttm)
$63.30M
Revenue Growth
+65.39%
P/S Ratio
6.73
Revenue / Employee
$498,386
Employees
127
Market Cap
425.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CARL News
- 6 days ago - Carlsmed files patent infringement lawsuit against DeGen Medical - TheFly
- 6 days ago - Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical - GlobeNewsWire
- 13 days ago - Carlsmed promotes Jeff Bertolini to COO role - TheFly
- 13 days ago - Carlsmed, Inc. Announces Chief Operating Officer Appointment - GlobeNewsWire
- 5 weeks ago - Carlsmed files $250M mixed securities shelf - TheFly
- 5 weeks ago - Carlsmed Registration statement: Registration filing - Filings
- 5 weeks ago - Carlsmed Transcript: Bank of America SMID Cap Virtual Conference - Transcripts
- 6 weeks ago - Carlsmed price target raised to $20 from $18 at Truist - TheFly